Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22898678 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer
Condition: Thyroid Neoplasms
Interventions: Drug: Vandetanib;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.